CVS Caremark to resume coverage of Lilly’s Zepbound weight loss drug
CVS Caremark will reinstate coverage for the weight loss drug Zepbound, effective October 1, following its removal from the formulary ...
CVS Caremark will reinstate coverage for the weight loss drug Zepbound, effective October 1, following its removal from the formulary ...
President Donald Trump announced an agreement with drugmakers Novo Nordisk and Eli Lilly to reduce the monthly out-of-pocket cost of ...
SummaryA head-to-head study published in the New England Journal of Medicine found that Eli Lilly’s obesity drug, Zepbound, resulted in ...
Reuters was ahead of competitors with news that Eli Lilly's unscheduled trading update revealed lower-than-expected fourth-quarter sales of the weight-loss ...
Copyright © 2026 News Wave
News Wave is not responsible for the content of external sites.